3rd Annual ADC Analytical Development Summit
Evvnt Promotion / evvnt
Archiv
16.04.2024 - 18.04.2024 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 08:00 AM - 03:45 PM
Kongressthemen
The updated ICH Q14 guidance from the FDA revising analytical procedures used for release and stability testing has shown higher product quality expectations from regulatory agencies. As analytical studies become an indispensable requirement to progress the antibody-drug conjugate space forward, so has the need for rigorous analytical methodologies that ensure product quality ahead of regulatory submissions.
The updated ICH Q14 guidance from the FDA revising analytical procedures used for release and stability testing has shown higher product quality expectations from regulatory agencies. As analytical studies become an indispensable requirement to progress the antibody-drug conjugate space forward, so has the need for rigorous analytical methodologies that ensure product quality ahead of regulatory submissions.
Kongressorganizer (PCO)
Hanson Wade Group
Hanson Wade Group
Anmerkungen
Brochure: https://go.evvnt.com/2097379-3?pid=4832
Speakers: Allison Torgesen, Quality Control Director, Bolt Biotherapeutics, Amit Katiyar, Senior Director - Late Stage Biologics, Exelixis, and more
Brochure: https://go.evvnt.com/2097379-3?pid=4832
Speakers: Allison Torgesen, Quality Control Director, Bolt Biotherapeutics, Amit Katiyar, Senior Director - Late Stage Biologics, Exelixis, and more
Anfragen und Anmeldung:
https://go.evvnt.com/2097379-2?pid=4832
Frau Jessica Durston
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
